Disease Severity Prediction by Spirometry in Adults with Visceral Leishmaniasis from Minas Gerais, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC TROP MED & HYGIENE
Citação
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, v.96, n.2, p.280-284, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Visceral leishmaniasis (VL) is associated with interstitial pneumonitis according to histology and radiology reports. However, studies to address the functional impact on respiratory function in patients are lacking. We assessed pulmonary function using noninvasive spirometry in a cross-sectional study of hospitalized adult VL patients from Minas Gerais, Brazil, without unrelated lung conditions or acute infections. Lung conditions were graded as normal, restrictive, obstructive, or mixed patterns, according to Brazilian consensus standards for spirometry. To control for regional patterns of lung function, we compared spirometry of patients with regional paired controls. Spirometry detected abnormal lung function in most VL patients (70%, 14/20), usually showing a restrictive pattern, in contrast to regional controls and the standards for normal tests. Alterations in spirometry measurements correlated with hypoalbuminemia, the only laboratory value indicative of severity of parasitic disease. Abnormalities did not correlate with unrelated factors such as smoking or occupation. Clinical data including pulmonary symptoms and duration of therapy were also unrelated to abnormal spirometry findings. We conclude that the severity of VL is correlated with a restrictive pattern of lung function according to spirometry, suggesting that there may be interstitial lung involvement in VL. Further studies should address whether spirometry could serve as an index of disease severity in the management of VL.
Palavras-chave
Referências
  1. ANDRADE Z A, 1959, Hospital (Rio J), V55, P371
  2. Cousins S, 2015, LANCET, V385, P1716, DOI 10.1016/S0140-6736(15)60877-7
  3. de Silva AA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0852-9
  4. Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
  5. Druzian AF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003982
  6. DUARTE MIS, 1989, T ROY SOC TROP MED H, V83, P73, DOI 10.1016/0035-9203(89)90712-8
  7. DUARTE MIS, 1986, REV I MED TROP, V28, P431
  8. Escobar H, 2011, CURR ALLERGY ASTHM R, V11, P473, DOI 10.1007/s11882-011-0220-9
  9. Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588
  10. Georgiadou SP, 2015, INT J INFECT DIS, V34, P46, DOI 10.1016/j.ijid.2015.02.021
  11. Hayes D, 2009, RESP CARE, V54, P1717
  12. Lunt A, 2016, RESP PHYSIOL NEUROBI, V222, P6, DOI 10.1016/j.resp.2015.11.006
  13. Murray HW, 2004, AM J TROP MED HYG, V71, P787
  14. Pereira CAC, 2002, J PNEUMOL S3, V28, ps1
  15. Ramsey KA, 2014, AM J RESP CRIT CARE, V190, P1111, DOI 10.1164/rccm.201407-1277OC
  16. Silva LC, 2013, INT J EXP PATHOL, V94, P133, DOI 10.1111/iep.12010
  17. Tan WC, 2015, THORAX, V70, P822, DOI 10.1136/thoraxjnl-2015-206938
  18. Tuon FF, 2009, PARASITE IMMUNOL, V31, P98, DOI 10.1111/j.1365-3024.2008.01080.x